TickerFactsScreenerDevelopers

Moleculin Biotech, Inc. (MBRX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2016: -$3.77M2017: -$7.32M2018: -$12.20M2019: -$17.20M2020: -$17.77M2021: -$18.95M2022: -$27.64M2023: -$23.59M2024: -$23.86M2025: -$22.73M-$22.73M
2016Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$22.73M+4.7%
2024-$23.86M-1.1%
2023-$23.59M+14.6%
2022-$27.64M-45.8%
2021-$18.95M-6.6%
2020-$17.77M-3.3%
2019-$17.20M-40.9%
2018-$12.20M-66.6%
2017-$7.32M-94.5%
2016-$3.77M—